We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
-8.05%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
AUM
$124M
AUM Growth
-$54.4M
Cap. Flow
-$39.6M
Cap. Flow %
-31.82%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
Reduced
Closed
1

Top Buys

Rank Stock Value
1
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$5.15M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$44.7M

Sector Composition

Rank Sector Weight
1 Healthcare 96.29%
2 Miscellaneous 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTL
1
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$58.8M 47.3%
3,489,533
ATXS
2
DELISTED
Astria Therapeutics
ATXS
$22.7M 18.22%
47,628
ASXC
3
DELISTED
Asensus Surgical, Inc.
ASXC
$18.7M 15.05%
580,515
OCUL icon
4
Ocular Therapeutix
OCUL
$2.38B
$18.1M 14.56%
1,932,607
RPTP
5
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$4.62M 3.71%
+888,132
New +$5.15M
EVAR
6
DELISTED
Lombard Medical, Inc.
EVAR
$1.46M 1.17%
1,077,499
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-1,103,981
Closed -$44.7M

Similar funds

SV Health Investors's Q4 2015 Portfolio in Review

As of Q4 2015, SV Health Investors held 7 positions worth $124M, down 30% from $179M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors withdrew a net $39.6M in Q4 2015, closing 1 position. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $44.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 100% a quarter earlier, followed by Miscellaneous.

Against the trend, SV Health Investors opened a new position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) worth $4.62M.

  • SV Health Investors's largest Q4 2015 buy was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 888,132 shares worth $4.62M.
  • SV Health Investors fully exited IVERIC bio, Inc. Common Stock in Q4 2015, selling an estimated $44.7M.
  • SV Health Investors's ten largest holdings make up 100% of its $124M portfolio in Q4 2015.
  • SV Health Investors opened 1 new position and closed 1 in Q4 2015.
  • SV Health Investors's portfolio value fell 30% quarter-over-quarter to $124M.

Based on SV Health Investors's 13F filing for Q4 2015, filed 16 Feb 2016.